| 1 |
CTLA4
💬
| [4] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis | Ipilimumab
Ipilimumab
💬
|
Ipilimumab
| [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 2 |
MC1R
💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Melanogenesis | Afamelanotide acetate
Afamelanotide acetate
💬
|
Afamelanotide
| [2] 159 159, 254 💬
|
| 3 |
MC1R
💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Melanogenesis | Afamelanotide
Afamelanotide
💬
|
Afamelanotide
| [2] 159 159, 254 💬
|
| 4 |
MTNR1A
💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 5 |
MTNR1B
💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 6 |
PDCD1
💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Nivolumab
Nivolumab
💬
|
Nivolumab
| [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 7 |
RARA
💬
| [5] Th17 cell differentiation Th17 cell differentiation, Estrogen signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia | Isotretinoin
Isotretinoin
💬
|
Isotretinoin
| [4] 36 36, 39, 159, 160 💬
|
| 8 |
RARB
💬
| [4] Pathways in cancer Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer, Gastric cancer | Isotretinoin
Isotretinoin
💬
|
Isotretinoin
| [4] 36 36, 39, 159, 160 💬
|